Skip to content

Comparison of Anesthetic Effect and safety of Ciprofloxacin and Propofol in Anesthesia for Ureteral Stent Removal

Comparison of Anesthetic Effect and Safety of Ciprofloxacin and Propofol in Anesthesia for Ureteral Stent Removal

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092923
Enrollment
Unknown
Registered
2024-11-26
Start date
2024-12-01
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The anesthetic efficacy, safety and adverse reactions of cypofol and propofol were compared during ureteral stent extraction under cystoscope

Interventions

cyclopol group (Group C):induced by cyclopol combined with remifentanil
propofol group (Group B):induced by propofol combined with remifentanil

Sponsors

The First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Male patients undergoing ureteral stent extraction under elective general anesthesia; 2. Age >= 18 and <= 80 years; 3. BMI 18~30 kg/m^2; 4. ASA grade I or II; 5. Volunteer and sign informed consent; 6. Vital signs met the following criteria: a) respiratory rate 10 and 24 beats / min; b) arterial oxygen saturation (SpO 2) 95% during respiration; c) systolic blood pressure 90 mmHg and 160 mmHg; d) diastolic blood pressure 60 mmHg and 100 mmHg; e) heart rate 55 and 100 bpm.

Exclusion criteria

Exclusion criteria: 1. Fasting water for less than 6 hours; 2. Obvious respiratory or circulatory dysfunction before surgery, significant abnormalities in blood routine and biochemical indicators, and severe neurological and psychiatric disorders; 3. Use benzodiazepines or opioids within one month, with contraindications or allergic reactions to benzodiazepines, opioids, propofol and its components;

Design outcomes

Primary

MeasureTime frame
VPS, Verbal Numerical Pain Score;

Secondary

MeasureTime frame
hypoxemia;injection pain;hypotension;

Countries

China

Contacts

Public ContactFang Fang

The First Affiliated Hospital of Zhengzhou University

26409717@qq.com+86 371 66862026

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026